These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24965824)

  • 1. Rituximab for childhood-onset nephrotic syndrome.
    Hodson EM; Craig JC
    Lancet; 2014 Oct; 384(9950):1242-3. PubMed ID: 24965824
    [No Abstract]   [Full Text] [Related]  

  • 2. Rituximab for patients with nephrotic syndrome.
    Arnold DF; Misbah SA
    Lancet; 2015 Jan; 385(9964):226. PubMed ID: 25706702
    [No Abstract]   [Full Text] [Related]  

  • 3. Rituximab for patients with nephrotic syndrome.
    Keijzer-Veen MG; Hebert D; Parekh RS;
    Lancet; 2015 Jan; 385(9964):225. PubMed ID: 25706701
    [No Abstract]   [Full Text] [Related]  

  • 4. Rituximab for patients with nephrotic syndrome.
    Shin JI; Kronbichler A
    Lancet; 2015 Jan; 385(9964):225-6. PubMed ID: 25706700
    [No Abstract]   [Full Text] [Related]  

  • 5. Rituximab for patients with nephrotic syndrome--authors' reply.
    Iijima K; Sako M; Nozu K; Nakamura H; Ito S
    Lancet; 2015 Jan; 385(9964):226-7. PubMed ID: 25706703
    [No Abstract]   [Full Text] [Related]  

  • 6. Nephrotic syndrome: Rituximab in childhood steroid-dependent nephrotic syndrome.
    Boyer O; Niaudet P
    Nat Rev Nephrol; 2013 Oct; 9(10):562-3. PubMed ID: 23938594
    [No Abstract]   [Full Text] [Related]  

  • 7. Nephrotic syndrome: Rituximab is safe and effective in FRNS and SDNS--but where to go from here?
    Razzak M
    Nat Rev Nephrol; 2014 Aug; 10(8):421. PubMed ID: 25003616
    [No Abstract]   [Full Text] [Related]  

  • 8. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
    Iijima K; Sako M; Nozu K; Mori R; Tuchida N; Kamei K; Miura K; Aya K; Nakanishi K; Ohtomo Y; Takahashi S; Tanaka R; Kaito H; Nakamura H; Ishikura K; Ito S; Ohashi Y;
    Lancet; 2014 Oct; 384(9950):1273-81. PubMed ID: 24965823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is rituximab effective in childhood nephrotic syndrome? Yes and no.
    Kemper MJ; Lehnhardt A; Zawischa A; Oh J
    Pediatr Nephrol; 2014 Aug; 29(8):1305-11. PubMed ID: 23820888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab in the treatment of nephrotic syndrome: a systematic review.
    Otukesh H; Hoseini R; Rahimzadeh N; Fazel M
    Iran J Kidney Dis; 2013 Jul; 7(4):249-56. PubMed ID: 23880800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should we consider MMF therapy after rituximab for nephrotic syndrome?
    Filler G; Huang SH; Sharma AP
    Pediatr Nephrol; 2011 Oct; 26(10):1759-62. PubMed ID: 21533869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab for childhood refractory nephrotic syndrome.
    Iijima K
    Pediatr Int; 2011 Oct; 53(5):617-621. PubMed ID: 21771179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term prognosis of patients with steroid-dependent nephrotic syndrome treated with rituximab].
    Kamei K; Okada M; Miyazono A; Sato M; Fujimaru T; Ogura M; Ito S
    Nihon Jinzo Gakkai Shi; 2013; 55(5):947-55. PubMed ID: 23980480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab in idiopathic nephrotic syndrome: does it make sense?
    Cara-Fuentes G; Kairalla JA; Ishimoto T; Rivard C; Johnson RJ; Garin EH
    Pediatr Nephrol; 2014 Aug; 29(8):1313-9. PubMed ID: 23793923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-treatment with high-dose prednisolone after rituximab infusion for childhood-onset steroid-resistant nephrotic syndrome.
    Fujinaga S; Hara T
    Pediatr Nephrol; 2014 Jul; 29(7):1291-2. PubMed ID: 24633445
    [No Abstract]   [Full Text] [Related]  

  • 16. New treatment strategies in idiopathic nephrotic syndrome.
    Ulinski T; Aoun B
    Minerva Pediatr; 2012 Apr; 64(2):135-43. PubMed ID: 22495188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a role for rituximab in the treatment of idiopathic childhood nephrotic syndrome?
    Smith GC
    Pediatr Nephrol; 2007 Jun; 22(6):893-8. PubMed ID: 17310362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome.
    Webb H; Jaureguiberry G; Dufek S; Tullus K; Bockenhauer D
    Pediatr Nephrol; 2016 Apr; 31(4):589-94. PubMed ID: 26525199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood nephrotic syndrome--current and future therapies.
    Greenbaum LA; Benndorf R; Smoyer WE
    Nat Rev Nephrol; 2012 Jun; 8(8):445-58. PubMed ID: 22688744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab for Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome in Adults: A Retrospective, Multicenter Study in Spain.
    DaSilva I; Huerta A; Quintana L; Redondo B; Iglesias E; Draibe J; Praga M; Ballarín J; Díaz-Encarnación M;
    BioDrugs; 2017 Jun; 31(3):239-249. PubMed ID: 28534103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.